Publication in refereed journal
香港中文大学研究人员 ( 现职)
陈德章教授 (肿瘤学系) |
全文
数位物件识别号 (DOI) http://dx.doi.org/10.1093/annonc/mdf179 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/202WOS source URL
其它资讯
摘要Nasopharyngeal carcinoma (NPC) is endemic in southern China where genetic abnormalities and Epstein-Barr virus (EBV) infection are critical in the pathogenesis of the disease, Circulating EBV-DNA has been shown to improve prognostication and monitoring of NPC patients. Radiotherapy is the mainstay treatment for early disease and concurrent cisplatin/radiotherapy has been demonstrated to prolong survival in locoregionally advanced disease. Ongoing studies of targeting agents and immunotherapeutic approaches may further improve treatment results.
着者Chan ATC, Teo PML, Johnson PJ
期刊名称Annals of Oncology
出版年份2002
月份7
日期1
卷号13
期次7
出版社OXFORD UNIV PRESS
页次1007 - 1015
国际标準期刊号0923-7534
电子国际标準期刊号1569-8041
语言英式英语
关键词Epstein-Barr virus; nasopharyngeal carcinoma; review; treatment
Web of Science 学科类别Oncology; ONCOLOGY